Skip to main content
. Author manuscript; available in PMC: 2008 Dec 1.
Published in final edited form as: Stroke. 2008 Sep 4;39(12):3268–3276. doi: 10.1161/STROKEAHA.108.517656

Table 6. Outcome Variables: CLEAR Trial Combination Pts Versus NINDS Stroke Trial rt-PA and Control Pts.

CLEAR NINDS rt-PA P Value CLEAR NINDS Control P Value
n or N 69 115 69 151
mRS score 0–1 or return to baseline* 21 (30%) 46 (40%) 0.19 21 (30%) 36 (24%) 0.30
Barthel index ≤95* 32 (46%) 53 (46%) 0.97 32 (46%) 57 (38%) 0.23
Glasgow outcome score=0* 28 (41%) 47 (41%) 0.97 28 (41%) 44 (29%) 0.09
Symptomatic ICH 1 (1%) 9 (8%) 0.08 1 (1%) 2 (1%) 1.0
Any ICH 8 (12%) 13 (11%) 0.95 8 (12%) 8 (5%) 0.10
Death at 90 days 15 (22%) 21 (18%) 0.56 15 (22%) 31 (20%) 0.84
Death at 7 days 9 (13%) 9 (8%) 0.25 9 (13%) 14 (9%) 0.40
NIHSS score decrease ≥4 in 24 hours* 29 (42%) 47 (41%) 0.88 29 (42%) 57 (38%) 0.55
NIHSS score ≤2 at 24 hours* 9 (13%) 15 (13%) 1.0 9 (13%) 8 (5%) 0.04

Data expressed as n (%).

*

Deaths and missing patients were coded as “bad” outcome.